Kintor Pharmaceutical Limited (9939.HK)

HKD 1.1

(-0.9%)

Total Liabilities Summary of Kintor Pharmaceutical Limited

Kintor Pharmaceutical Limited's latest annual total liabilities in 2023 was 411.12 Million CNY , up 73321.1% from previous year.
Kintor Pharmaceutical Limited's latest quarterly total liabilities in 2023 FY was 411.12 Million CNY , up 73321.1% from previous quarter.
Kintor Pharmaceutical Limited reported annual total liabilities of 559.94 Thousand CNY in 2022, up 35.64% from previous year.
Kintor Pharmaceutical Limited reported annual total liabilities of 412.83 Thousand CNY in 2021, up 20.17% from previous year.
Kintor Pharmaceutical Limited reported quarterly total liabilities of 548.63 Thousand CNY for 2023 Q2, down -2.02% from previous quarter.
Kintor Pharmaceutical Limited reported quarterly total liabilities of 411.12 Million CNY for 2023 Q4, up 74835.48% from previous quarter.

Annual Total Liabilities Chart of Kintor Pharmaceutical Limited (2023 - 2014)

Historical Annual Total Liabilities of Kintor Pharmaceutical Limited (2023 - 2014)

Year	Total Liabilities	Total Liabilities Growth
2023	411.12 Million CNY	73321.1%
2022	559.94 Thousand CNY	35.64%
2021	412.83 Thousand CNY	20.17%
2020	343.54 Thousand CNY	87.0%
2019	183.71 Thousand CNY	6.86%
2018	171.92 Thousand CNY	-99.62%
2017	45.5 Million CNY	45226.62%
2016	100.39 Thousand CNY	-74.18%
2015	388.8 Thousand CNY	-2.07%
2014	397.01 Thousand CNY	0.0%

Year	Total Liabilities	Total Liabilities Growth
2023 FY	411.12 Million CNY	73321.1%
2023 Q2	548.63 Thousand CNY	-2.02%
2023 Q4	411.12 Million CNY	74835.48%
2022 Q4	559.94 Thousand CNY	-0.51%
2022 FY	559.94 Thousand CNY	35.64%
2022 Q2	562.82 Thousand CNY	36.33%
2021 Q2	240.86 Thousand CNY	-29.89%
2021 FY	412.83 Thousand CNY	20.17%
2021 Q4	412.83 Thousand CNY	71.39%
2020 Q2	376.32 Thousand CNY	104.85%
2020 Q4	343.54 Thousand CNY	-8.71%
2020 FY	343.54 Thousand CNY	87.0%
2019 FY	183.71 Thousand CNY	6.86%
2019 Q4	183.71 Thousand CNY	0.0%
2018 FY	171.92 Thousand CNY	-99.62%
2017 Q2	17.55 Million CNY	17382.04%
2017 Q4	45.5 Million CNY	159.28%
2017 FY	45.5 Million CNY	45226.62%
2016 FY	100.39 Thousand CNY	-74.18%
2016 Q4	100.39 Thousand CNY	0.0%
2015 FY	388.8 Thousand CNY	-2.07%
2014 FY	397.01 Thousand CNY	0.0%

Peer Total Liabilities Comparison of Kintor Pharmaceutical Limited

Name	Total Liabilities	Total Liabilities Difference
Uni-Bio Science Group Limited	152.81 Million HKD	-169.026%
CK Life Sciences Int'l., (Holdings) Inc.	7.05 Billion HKD	94.175%